Department of Chemistry, School of Sciences and Humanities (SSH) Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
Sensors (Basel). 2023 Feb 1;23(3):1605. doi: 10.3390/s23031605.
Excessive protein excretion in human urine is an early and sensitive marker of diabetic nephropathy and primary and secondary renal disease. Kidney problems, particularly chronic kidney disease, remain among the few growing causes of mortality in the world. Therefore, it is important to develop an efficient, expressive, and low-cost method for protein determination. Surface enhanced Raman spectroscopy (SERS) methods are potential candidates to achieve these criteria. In this paper, a SERS method was developed to distinguish patients with proteinuria from the healthy group. Commercial gold nanoparticles (AuNPs) with diameters of 60 nm and 100 nm, and silver nanoparticles (AgNPs) with a diameter of 100 nm were tested on the surface of four different substrates including silver and gold films, silicon, and aluminum tape. SERS spectra were acquired from 111 unique human urine samples prepared and measured for each of the seven different nanoparticle plus substrate combinations. Data analysis by the PCA-LDA algorithm and the ROC curves gave results for the diagnostic figures of merits. The best sensitivity, specificity, accuracy, and AUC were 0.91, 0.84, 0.88, and 0.94 for the set with 100 nm Au NPs on the silver substrate, respectively. Among the three metal substrates, the substrate with AuNPs and Al tape performed slightly worse than the other three substrates, and 100 nm gold nanoparticles on average produced better results than 60 nm gold nanoparticles. The 60 nm diameter AuNPs and silicon, which is about one order of magnitude more cost-effective than AuNPs and gold film, showed a relative performance close to the performance of 60 nm AuNPs and Au film (average AUC 0.88 (Si) vs. 0.89 (Au)). This is likely the first reported application of unmodified silicon in SERS substrates applied for direct detection of proteins in any biofluid, particularly in urine. These results position silicon and AuNPs@Si in particular as a perspective SERS substrate for direct urine analysis, including clinical diagnostics of proteinuria.
人体尿液中蛋白质的过度排泄是糖尿病肾病以及原发性和继发性肾病的早期和敏感标志物。肾脏问题,特别是慢性肾病,仍然是世界上少数几个死亡率不断上升的原因之一。因此,开发一种高效、有表现力且低成本的蛋白质测定方法非常重要。表面增强拉曼光谱(SERS)方法是实现这些标准的潜在候选方法。在本文中,开发了一种 SERS 方法来区分蛋白尿患者和健康组。测试了直径为 60nm 和 100nm 的商用金纳米粒子(AuNPs)和直径为 100nm 的银纳米粒子(AgNPs)在包括银和金膜、硅和铝带在内的四种不同基底上的表面增强拉曼光谱。从 111 个独特的人类尿液样本中获取 SERS 光谱,每个样本都为七种不同的纳米粒子加基底组合中的每一种进行了制备和测量。通过 PCA-LDA 算法和 ROC 曲线进行数据分析,得出了诊断特征的结果。对于具有银基底上 100nmAu NPs 的组,最佳的灵敏度、特异性、准确性和 AUC 分别为 0.91、0.84、0.88 和 0.94。在三种金属基底中,AuNPs 和 Al 带基底的性能略逊于其他三种基底,平均而言,100nm 金纳米粒子的性能优于 60nm 金纳米粒子。60nm 直径的 AuNPs 和硅,其成本效益比 AuNPs 和金膜高一个数量级,表现出与 60nm AuNPs 和金膜相当的性能(平均 AUC 0.88(Si)与 0.89(Au))。这可能是首次报道在任何生物流体中,特别是在尿液中,直接检测蛋白质时,未修饰的硅在 SERS 基底中的应用。这些结果使硅和 AuNPs@Si 特别成为直接尿液分析的有前途的 SERS 基底,包括蛋白尿的临床诊断。